Main > > >NEUROFIBROMATOSIS TYPE 1. *

---

Onco.>Treat.: Selumetinib
USA Approval Date: 2020. 04.10.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 04.13.


>NEUROFIBROMATOSIS TYPE 1. *'s products
This section has no products